Inactive Instrument

HELX ACQU Stock price

Equities

HLXA

KYG4444C1024

Dynamic Chart
Helix Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Helix Acquisition Corp. will Change its Name to MoonLake Immunotherapeutics CI
Helix Acquisition Corp.(NasdaqCM:HLXA) dropped from NASDAQ Composite Index CI
MoonLake Immunotherapeutics AG completed the acquisition of Helix Acquisition Corp. from a group of shareholders in a reverse merger transaction. CI
Helix Acquisition Corp. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Helix Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
Helix Acquisition Corp. Auditor Raises 'Going Concern' Doubt CI
Helix Acquisition Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Helix Acquisition : MoonLake to Merge with SPAC Helix Acquisition to Go Public MT
MoonLake Immunotherapeutics AG signed a non-binding letter of intent to acquire Helix Acquisition Corp. from a group of shareholders for approximately $350 million in a reverse merger transaction. CI
Helix Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Helix Acquisition Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Helix Acquisition Corp. Announces Management Changes CI
Certain Class B Ordinary Shares of Helix Acquisition Corp. are subject to a Lock-Up Agreement Ending on 19-APR-2021. CI
Helix Acquisition Corp. Announces Executive Changes CI
More news
Helix Acquisition Corp is a blank check company. The Company is incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company is primarily focused on the healthcare industry.
Sector
-
More about the company
  1. Stock
  2. Equities
  3. Stock HELX ACQU - Nasdaq